David J. Inwards

15.3k total citations
265 papers, 8.0k citations indexed

About

David J. Inwards is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, David J. Inwards has authored 265 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 189 papers in Pathology and Forensic Medicine, 113 papers in Oncology and 98 papers in Genetics. Recurrent topics in David J. Inwards's work include Lymphoma Diagnosis and Treatment (187 papers), Chronic Lymphocytic Leukemia Research (89 papers) and Viral-associated cancers and disorders (59 papers). David J. Inwards is often cited by papers focused on Lymphoma Diagnosis and Treatment (187 papers), Chronic Lymphocytic Leukemia Research (89 papers) and Viral-associated cancers and disorders (59 papers). David J. Inwards collaborates with scholars based in United States, Italy and United Kingdom. David J. Inwards's co-authors include Stephen M. Ansell, Ivana N. Micallef, Luis F. Porrata, Thomas E. Witzig, Thomas M. Habermann, Patrick B. Johnston, Svetomir N. Markovic, Joseph P. Colgan, Paul J. Kurtin and Ayalew Tefferi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

David J. Inwards

256 papers receiving 7.8k citations

Peers

Countries citing papers authored by David J. Inwards

Since Specialization

Citations

This map shows the geographic impact of David J. Inwards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Inwards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Inwards more than expected).

Fields of papers citing papers by David J. Inwards

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Inwards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Inwards. The network helps show where David J. Inwards may publish in the future.

Co-authorship network of co-authors of David J. Inwards

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Inwards. A scholar is included among the top collaborators of David J. Inwards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Inwards. David J. Inwards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy 2024 ·Haematologica ·Aung M. Tun, Yucai Wang, Seth Maliske, Ivana N. Micallef, David J. Inwards, Thomas M. Habermann, Luis F. Porrata, Jonas Paludo, José C. Villasboas, Allison Rosenthal, Mohamed A. Kharfan‐Dabaja, Stephen M. Ansell, Grzegorz S. Nowakowski, Umar Farooq, Patrick B. Johnston	4
2	Autologous Stem Cell Transplant in Fit Patients With Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy 2024 ·Transplantation and Cellular Therapy ·Aung M. Tun, Yucai Wang, Seth Maliske, Ivana N. Micallef, David J. Inwards, Thomas M. Habermann, Luis F. Porrata, Jonas Paludo, José C. Villasboas, Allison Rosenthal, Mohamed A. Kharfan‐Dabaja, Stephen M. Ansell, Grzegorz S. Nowakowski, Umar Farooq, Patrick B. Johnston	1
3	Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study 2023 ·Blood Cancer Journal ·Allison M. Bock, Jennifer Gile, Melissa C. Larson, (unknown), (unknown), Seth Maliske, Matthew J. Maurer, Brian Kabat, Jonas Paludo, David J. Inwards, Sabarish Ayyappan, Brian K. Link, Stephen M. Ansell, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski, James R. Cerhan, Umar Farooq, Yucai Wang	3
4	PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts 2022 ·Blood Cancer Journal ·(unknown), Levi Pederson, Betsy LaPlant, Raphael Mwangi, Matthew J. Maurer, Jason R. Young, William R. Macon, Rebecca L. King, Yucai Wang, James R. Cerhan, Andrew L. Feldman, David J. Inwards, Ivana N. Micallef, Patrick B. Johnston, Luis F. Porrata, Stephen M. Ansell, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski	5
5	Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic Experience 2022 ·Clinical Lymphoma Myeloma & Leukemia ·(unknown), Muhamad Alhaj Moustafa, Liuyan Jiang, Madiha Iqbal, Karan Seegobin, (unknown), Ernesto Ayala, (unknown), Allison Rosenthal, Jonas Paludo, Ivana N. Micallef, Patrick B. Johnston, David J. Inwards, Thomas M. Habermann, Mohamed A. Kharfan‐Dabaja, Thomas E. Witzig, Grzegorz S. Nowakowski, Han W. Tun	2
6	Long-Term Health-Related Quality of Life of Autologous Hematopoietic Cell Transplantation Patients and Nontransplant Patients With Aggressive Lymphoma: A Prospective Cohort Analysis 2022 ·JCO Oncology Practice ·Christopher Strouse, Melissa C. Larson, Shawna L. Ehlers, Kathleen J. Yost, Matthew J. Maurer, Stephen M. Ansell, David J. Inwards, Patrick B. Johnston, Ivana N. Micallef, Brian K. Link, Umar Farooq, James R. Cerhan, Carrie A. Thompson	2
7	Lines of Therapy before Autologous Stem Cell Transplant (ASCT) and CAR-T Infusion Affect Outcomes in Aggressive Non-Hodgkin’s Lymphoma (NHL) 2021 ·Transplantation and Cellular Therapy ·Arushi Khurana, Matthew Hathcock, Thomas M. Habermann, Abdullah S. Al Saleh, (unknown), Tuan Truong, N. Nora Bennani, Jonas Paludo, José C. Villasboas, (unknown), David J. Inwards, Luis F. Porrata, Patrick B. Johnston, Ivana N. Micallef, Yi Lin	1
8	Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomes 2021 ·Blood Advances ·Alessia Castellino, Yucai Wang, Melissa C. Larson, Matthew J. Maurer, Brian K. Link, Umar Farooq, Andrew L. Feldman, Sergei Syrbu, Thomas M. Habermann, Jonas Paludo, David J. Inwards, Thomas E. Witzig, Stephen M. Ansell, Cristine Allmer, Susan L. Slager, Jonathon B. Cohen, Peter Martin, James R. Cerhan, Grzegorz S. Nowakowski	13
9	Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era 2021 ·American Journal of Hematology ·Nicholas Boddicker, Melissa C. Larson, Alessia Castellino, Joerg Herrmann, David J. Inwards, Gita Thanarajasingam, Matthew J. Maurer, Cristine Allmer, Thomas E. Witzig, Grzegorz S. Nowakowski, Thomas M. Habermann, Hector R. Villarraga, Susan L. Slager, James R. Cerhan, Carrie A. Thompson	10
10	Impact of Cell of Origin on Outcomes After Autologous Hematopoietic Cell Transplant in Diffuse Large B-Cell Lymphoma 2021 ·Clinical Lymphoma Myeloma & Leukemia ·Madiha Iqbal, (unknown), Jonas Paludo, Allison Rosenthal, Zhuo Li, (unknown), Muhamad Alhaj Moustafa, David J. Inwards, Luis F. Porrata, Ivana N. Micallef, José C. Villasboas, Patrick B. Johnston, Stephen M. Ansell, Craig B. Reeder, Hemant S. Murthy, Vivek Roy, James M. Foran, Han W. Tun, Mohamed A. Kharfan‐Dabaja, Ernesto Ayala	2
11	Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma 2021 ·Blood Cancer Journal ·Alessia Castellino, Aung M. Tun, Yucai Wang, Thomas M. Habermann, Rebecca L. King, Kay M. Ristow, James R. Cerhan, David J. Inwards, Jonas Paludo, Stephen M. Ansell, Thomas E. Witzig, Grzegorz S. Nowakowski	7
12	History of autoimmune conditions and lymphoma prognosis 2018 ·Blood Cancer Journal ·Geffen Kleinstern, Matthew J. Maurer, Mark Liebow, Thomas M. Habermann, Jean L. Koff, Cristine Allmer, Thomas E. Witzig, Grzegorz S. Nowakowski, Ivana N. Micallef, Patrick B. Johnston, David J. Inwards, Carrie A. Thompson, Andrew L. Feldman, Brian K. Link, Christopher R. Flowers, Susan L. Slager, James R. Cerhan	24
13	The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma 2015 ·Blood ·Thomas E. Witzig, Craig B. Reeder, Jing Han, Betsy LaPlant, Mary Stenson, Han W. Tun, William R. Macon, Stephen M. Ansell, Thomas M. Habermann, David J. Inwards, Ivana N. Micallef, Patrick B. Johnston, Luis F. Porrata, Joseph P. Colgan, Svetomir N. Markovic, Grzegorz S. Nowakowski, Mamta Gupta	83
14	Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non–Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study 2014 ·Journal of Clinical Oncology ·Grzegorz S. Nowakowski, Betsy LaPlant, William R. Macon, Craig B. Reeder, James M. Foran, Garth D. Nelson, Carrie A. Thompson, Candido E. Rivera, David J. Inwards, Ivana N. Micallef, Patrick B. Johnston, Luis F. Porrata, Stephen M. Ansell, Randy D. Gascoyne, Thomas M. Habermann, Thomas E. Witzig	268
15	The absolute monocyte count is associated with overall survival in patients newly diagnosed with follicular lymphoma 2011 ·Leukemia & lymphoma ·Ryan A. Wilcox, Kay M. Ristow, Thomas M. Habermann, David J. Inwards, Ivana N. Micallef, Patrick B. Johnston, Joseph P. Colgan, Grzegorz S. Nowakowski, Stephen M. Ansell, Thomas E. Witzig, Svetomir N. Markovic, Luis F. Porrata	76
16	Phase I Study of Ipilimumab, an Anti–CTLA-4 Monoclonal Antibody, in Patients with Relapsed and Refractory B-Cell Non–Hodgkin Lymphoma 2009 ·Clinical Cancer Research ·Stephen M. Ansell, Sara A. Hurvitz, Patricia Koenig, Betsy LaPlant, Brian Kabat, (unknown), Thomas M. Habermann, David J. Inwards, Meena Verma, Reiko Yamada, Charles Erlichman, Israel Lowy, John M. Timmerman	263
17	Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome 2008 ·European Journal Of Haematology ·Angela Dispenzieri, Martha Q. Lacy, Suzanne R. Hayman, Shaji Kumar, Francis K. Buadi, David Dingli, Mark R. Litzow, Dennis A. Gastineau, David J. Inwards, Michelle A. Elliott, Ivana N. Micallef, Stephen M. Ansell, William J. Hogan, Luis F. Porrata, Patrick A. Johnston, Bekele Afessa, Alan H. Bryce, Robert A. Kyle, Morie A. Gertz	78
18	Time of relapse after initial therapy significantly adds to the prognostic value of the IPI-R in patients with relapsed DLBCL undergoing autologous stem cell transplantation 2008 ·Bone Marrow Transplantation ·Luciano J. Costa, Ivana N. Micallef, David J. Inwards, Patrick B. Johnston, Luis F. Porrata, Stephen M. Ansell	20
19	A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B‐cell lymphoma 2006 ·Cancer ·Ivana N. Micallef, Brad S. Kahl, Matthew J. Maurer, Ahmet Doǧan, Stephen M. Ansell, Joseph P. Colgan, Susan M. Geyer, David J. Inwards, William L. White, Thomas M. Habermann	32
20	Peripheral Blood Stem Cell Transplantation: Historical Perspective, Current Status, and Prospects for the Future 1992 ·Transfusion Medicine Reviews ·David J. Inwards, Anne Kessinger	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact